UNIONDALE, NY, Feb. 03, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (OTC: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics and consumer products company, today announced that ...
ProPhase Labs (PRPH) has initiated a potential sale or strategic partnership process for BE-Smart, its clinically validated esophageal cancer risk stratification test. As part of this process, ...
ProPhase Labs Inc. (Nasdaq: PRPH) (“ProPhase”) is a next-generation biotech, genomics and diagnostics company. Our goal is to create a healthier world with bold action and the power of insight. We’re ...
UNIONDALE, NY - ProPhase Labs, Inc. (NASDAQ:PRPH) announced Wednesday it is engaged in merger and acquisition discussions that could potentially recognize the company’s value "at multiples of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results